The estimated Net Worth of John L Slebir is at least $768 ezer dollars as of 1 July 2015. Mr. Slebir owns over 9,215 units of VIVUS stock worth over $29,662 and over the last 14 years he sold VVUS stock worth over $32,168. In addition, he makes $706,636 as Senior Vice President - Business Development, General Counsel és Secretary at VIVUS.
Sign up
Mr. Slebir VVUS stock SEC Form 4 insiders trading
John has made over 4 trades of the VIVUS stock since 2012, according to the Form 4 filled with the SEC. Most recently he sold 9,215 units of VVUS stock worth $21,379 on 1 July 2015.
The largest trade he's ever made was exercising 10,000 units of VIVUS stock on 18 July 2012 worth over $72,700. On average, John trades about 1,087 units every 51 days since 2011. As of 1 July 2015 he still owns at least 63,584 units of VIVUS stock.
You can see the complete history of Mr. Slebir stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
John Slebir biography
John L. Slebir J.D. Esq. serves as Senior Vice President - Business Development, General Counsel, Secretary of the Company. Mr. Slebir has served as our Senior Vice President, Business Development and General Counsel since January 2014, and, since June 2012, he also has served as our Secretary. From June 2011 until January 2014, Mr. Slebir served as our Vice President, Business Development and General Counsel, from January 2011 until June 2011, he served as our Vice President, General Counsel, and, from September 2009 until January 2011, he served as our General Counsel on a part-time basis. From March 1999 until January 2011, Mr. Slebir served as an attorney at Wilson Sonsini Goodrich & Rosati, P.C., specializing in corporate securities and corporate governance. Prior to joining Wilson Sonsini Goodrich & Rosati, P.C., Mr. Slebir was an attorney at two prominent Bay Area law firms specialized in insurance and sporting equipment defense litigation. Mr. Slebir holds a B.A. in Communications from San Diego State University and a J.D. from Santa Clara University School of Law.
What is the salary of John Slebir?
As the Senior Vice President - Business Development, General Counsel és Secretary of VIVUS, the total compensation of John Slebir at VIVUS is $706,636. There are 1 executives at VIVUS getting paid more, with John Amos having the highest compensation of $873,894.
How old is John Slebir?
John Slebir is 54, he's been the Senior Vice President - Business Development, General Counsel és Secretary of VIVUS since 2014. There are 6 older and 3 younger executives at VIVUS. The oldest executive at VIVUS, Inc. is Edward Kangas, 75, who is the Independent Director.
What's John Slebir's mailing address?
John's mailing address filed with the SEC is C/O VIVUS, INC., 900 E. HAMILTON AVE., SUITE 550, CAMPBELL, CA, 95008.
Insiders trading at VIVUS
Over the last 21 years, insiders at VIVUS have traded over $6,261,269 worth of VIVUS stock and bought 5,180,746 units worth $13,074,554 . The most active insiders traders include Tide Capital, Llc North Tid..., Alexander J Denner és Ernest Mario. On average, VIVUS executives and independent directors trade stock every 39 days with the average trade being worth of $35,394. The most recent stock trade was executed by John P. Amos on 1 March 2019, trading 11,000 units of VVUS stock currently worth $53,350.
What does VIVUS do?
VIVUS, Inc. engages in the development and commercialization of novel therapeutic products. The firm's products are indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and is headquartered in Campbell, CA.
What does VIVUS's logo look like?
Complete history of Mr. Slebir stock trades at VIVUS
VIVUS executives and stock owners
VIVUS executives and other stock owners filed with the SEC include:
-
John Amos,
Chief Executive Officer, Director -
John Slebir,
Senior Vice President - Business Development, General Counsel, Secretary -
Santosh Varghese,
Senior Vice President, Chief Medical Officer -
Mark Oki,
Chief Financial Officer, Senior Vice President, Chief Accounting Officer -
Thomas King,
Independent Director -
David Norton,
Independent Chairman of the Board -
Jill Frizzley,
Independent Director -
Herman Rosenman,
Independent Director -
Jorge Plutzky,
Independent Director -
Edward Kangas,
Independent Director -
Karen Ferrell,
Independent Director -
Allan Shaw,
Director -
Herm Rosenman,
Director -
Eric W Roberts,
Director -
Tide Capital, Llc North Tid...,
-
Seth H. Z. Fischer,
Chief Executive Officer -
Mayu Sris,
Director -
Kenneth Suh,
President -
Wesley Day,
Vice President, Clinical -
Michael /Ny/ Miller,
Chief Commercial Officer -
Wang Changjin,
VP, Business Development -
Virgil A Place,
Chairman & CSO -
Graham Strachan,
Director -
Samuel F Colin,
Director -
Ernest Mario,
Director -
Anthony P. Zook,
Chief Executive Officer -
John W Dietrich,
Vice President, R & D -
Terry Nida,
VP, Worldwide Marketing/ -
Svai S Sanford,
Interim CFO -
Mario M Rosati,
Director -
Alexander J Denner,
Director -
Jon C Biro,
10% owner -
J Martin Carroll,
Director -
Robert N Wilson,
Director -
Alexander J Sarissa Capital...,
-
M. Scott Oehrlein,
Chief Operations Officer -
Timothy E Morris,
VP, Finance and CFO -
Leland F Wilson,
President & CEO -
Linda M Dairiki Shortliffe,
Director -
Charles J Casamento,
Director -
Lee Perry,
Vice President & Chief -
Jacob Pieter Kastelein Joha...,
Director -
Michael J Astrue,
Director -
Mark B Logan,
Director -
Michael Patrick Miller,
SVP, Chief Commercial Officer -
Guy P Marsh,
VP, Operations & General Mgr. -
Neil Gesundheit,
VP, Chief Medical Officer -
Larry J Strauss,
Vice President, Finance & CFO -
James R Nickel,
Vice President, Clinical -
Peter Y Tam,
VP, Business Planning -
Carol Zoltowski,
Vice President, Regulatory -
Lori Forrest,
VP, Operations & General Mgr.